•
Dec 31, 2023

Immix Biopharma Q4 2023 Earnings Report

Total Revenue
$4.78K
Previous year: -$89.5M
-100.0%
EPS
-$0.24
Previous year: -$0.27
-11.1%
Gross Profit
$1.71K
Previous year: -$89.5M
-100.0%
Cash and Equivalents
$17.5M
Previous year: $13.4M
+30.3%
Free Cash Flow
-$2.69M
Total Assets
$19.9M
Previous year: $14.9M
+33.7%

Immix Biopharma

Immix Biopharma